OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1
Feng Gao, Qiaoping Xu, Zhe Tang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 101

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 39

Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 20

Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
Shuyan He, Lu Zheng, Chunjian Qi
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
Shenglong Li, Yue Kang, Yu Zeng
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189033-189033
Closed Access | Times Cited: 41

Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12

Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 12

Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 1

The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
Yu Wu, Wenyan Han, Hairong Dong, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 6

Glioma-derived exosome Lncrna Agap2-As1 promotes glioma proliferation and metastasis by mediating Tgf-β1 secretion of myeloid-derived suppressor cells
Yanlong Tian, Xiao Gao, Xuechao Yang, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29949-e29949
Open Access | Times Cited: 6

Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting
Antonella Barone, Anna Maria Zimbo, Nicola d’Avanzo, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 12, pp. 3154-3168
Open Access | Times Cited: 14

Exosomal hsa_circ_000200 as a potential biomarker and metastasis enhancer of gastric cancer via miR-4659a/b-3p/HBEGF axis
Xiaojuan Huang, Yan Wang, Hui‐Ting Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14

CircRNAs regulate the crosstalk between inflammation and tumorigenesis: The bilateral association and molecular mechanisms
Javeria Qadir, Shuo‐Yang Wen, Hui Yuan, et al.
Molecular Therapy (2022) Vol. 31, Iss. 6, pp. 1514-1532
Open Access | Times Cited: 21

Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells
Xinyu Tian, Ting Wang, Han Shen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 108-121
Closed Access | Times Cited: 11

The science of exosomes: Understanding their formation, capture, and role in cellular communication
Kiavash Hushmandi, Seyed Hassan Saadat, Mehdi Raei, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155388-155388
Closed Access | Times Cited: 4

Circular RNAs in human diseases
Yuanyong Wang, Jin Zhang, Yu‐Chen S. H. Yang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 4

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4

Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access

Immunoregulatory role of exosomal circRNAs in the tumor microenvironment
Changsheng Lv, Jinhao Chen, Yuxiang Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Role of circular RNAs in cancer therapy resistance
Wenjuan Liu, Jiling Niu, Yanfei Huo, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Prospect of extracellular vesicles in tumor immunotherapy
Wenbo Xia, Yunhan Tan, Y.-P. Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Small extracellular vesicles: crucial mediators for prostate cancer
Sijie Tang, Huiying Cheng, Xueyan Zang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications
Sha Mao, Junyan Li, Jiahui Huang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer
Takuro Kobayashi, Masayoshi Nagata, Tsuyoshi Hachiya, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top